Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Defining antimicrobial resistance in cystic fibrosis

Research output: Contribution to journalReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Johansen, Helle Krogh ; Antimicrobial Resistance in Cystic Fibrosis International Working Group. / Defining antimicrobial resistance in cystic fibrosis. In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2018 ; Vol. 17, No. 6. pp. 696-704.

Bibtex

@article{ffda56ad3cc14da4b1783033fb848b62,
title = "Defining antimicrobial resistance in cystic fibrosis",
abstract = "Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.",
author = "Kidd, {Timothy J} and Rafael Canton and Miquel Ekkelenkamp and Johansen, {Helle Krogh} and Peter Gilligan and LiPuma, {John J} and Bell, {Scott C} and Elborn, {J Stuart} and Flume, {Patrick A} and VanDevanter, {Donald R} and Waters, {Valerie J} and {Antimicrobial Resistance in Cystic Fibrosis International Working Group}",
note = "Copyright {\circledC} 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.",
year = "2018",
month = "11",
doi = "10.1016/j.jcf.2018.08.014",
language = "English",
volume = "17",
pages = "696--704",
journal = "Journal of Cystic Fibrosis",
issn = "1569-1993",
publisher = "Elsevier BV",
number = "6",

}

RIS

TY - JOUR

T1 - Defining antimicrobial resistance in cystic fibrosis

AU - Kidd, Timothy J

AU - Canton, Rafael

AU - Ekkelenkamp, Miquel

AU - Gilligan, Peter

AU - LiPuma, John J

AU - Bell, Scott C

AU - Elborn, J Stuart

AU - Flume, Patrick A

AU - VanDevanter, Donald R

AU - Waters, Valerie J

AU - Antimicrobial Resistance in Cystic Fibrosis International Working Group

A2 - Johansen, Helle Krogh

N1 - Copyright © 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

PY - 2018/11

Y1 - 2018/11

N2 - Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.

AB - Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.

U2 - 10.1016/j.jcf.2018.08.014

DO - 10.1016/j.jcf.2018.08.014

M3 - Review

VL - 17

SP - 696

EP - 704

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

IS - 6

ER -

ID: 56201233